Note: Ingredients listed on restricted chemical lists
EC/CAS
103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
General Information
Revision date
2020-11-12
Product name
DIMETAPP COLD & FLU CAPSULES
supplier name
GlaxoSmithKline Korea
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Korea
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319, H412
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
A. Hazard category/Classification
Physical hazards
Not classified.
Health hazards
Skin corrosion/irritation Category 2 Serious eye damage/eye irritation Category 2
Environmental hazards
Hazardous to the aquatic environment, Category 3
Long term hazards
B. Warning label items including precautionary statement
Signal word
Warning
Hazard statements
H315 Causes skin irritation. H319 Causes serious eye irritation. H412 Harmful to aquatic life with long lasting effects.
Prevention
P264 Wash thoroughly after handling. P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection/face protection.
Response
P302 + P352 IF ON SKIN: Wash with plenty of water/. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P321 Specific treatment (see on this label). P332 + P313 If skin irritation occurs: Get medical advice/attention. P337 + P313 If eye irritation persists: Get medical advice/attention. P362 + P364 Take off contaminated clothing and wash it before reuse.
Disposal
P501 Dispose of contents/container (in accordance with related regulations). C. Other hazards not included None known. in the hazard category criteria (e.g. dust explosion hazard)
Additional information
22.8 % of the mixture consists of component(s) of unknown acute oral toxicity. 82.3 % of the mixture consists of component(s) of unknown acute dermal toxicity. 68.3 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 64.8 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
